Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It can arise in extranodal sites and solid organs, leading to significant clinical implications such as systemic symptoms and organ dysfunction. Accurate coding with ICD-10 Code C83.398 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this aggressive malignancy.
ICD-10 Code C83.398 represents Diffuse large B-cell lymphoma of extranodal and solid organ sites. This code is used when the lymphoma is identified outside of lymph nodes, affecting organs such as the liver, spleen, or gastrointestinal tract. It is crucial for clinical documentation and billing to accurately reflect the diagnosis, particularly in cases where the disease may present with complications or require specialized treatment.
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can manifest in extranodal sites, leading to varied clinical presentations. The condition often requires prompt medical intervention due to its rapid progression and potential for systemic involvement. Understanding its clinical features is vital for effective diagnosis and treatment.
ICD-10 Code C83.398 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Diffuse large B-cell lymphoma. This code aids in capturing the complexity of the condition, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C83.398 connects subjective patient reports and objective clinical findings to a formal diagnosis of Diffuse large B-cell lymphoma. This linkage is crucial for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Diffuse large B-cell lymphoma requires urgent medical attention, often necessitating hospitalization for intensive treatment. Standard therapeutic approaches include chemotherapy and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.398 is critical in medical billing, particularly in hospital, emergency room, or oncology settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 77014 | Radiologic guidance for needle placement. |
| 85025 | Complete blood count with differential. |
| 88305 | Pathology examination of tissue, including biopsy. |
Common Questions About Using ICD-10 Code C83.398 for Diffuse large B-cell lymph of extrnod and solid organ sites
What are the common symptoms of Diffuse large B-cell lymphoma?
Common symptoms include unexplained weight loss, fever, night sweats, and swollen lymph nodes. Patients may also experience abdominal pain or fullness if extranodal sites are involved.
How is Diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy to confirm the presence of large B-cells. Laboratory tests may also be conducted to assess overall health.
What treatment options are available for Diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy regimens such as R-CHOP, and may include radiation therapy depending on the stage and location of the disease. Supportive care is also essential.
How does ICD-10 Code C83.398 impact billing?
ICD-10 Code C83.398 is crucial for accurate billing as it specifies the diagnosis of Diffuse large B-cell lymphoma. Proper documentation ensures compliance and justifies the medical necessity of treatments provided.
Clinical Notes
SOAP notes
DAP notes
AI medical notes